Your browser doesn't support javascript.
loading
Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas.
Sasso, Maria Stella; Mitrousis, Nikolaos; Wang, Yue; Briquez, Priscilla S; Hauert, Sylvie; Ishihara, Jun; Hubbell, Jeffrey A; Swartz, Melody A.
Afiliación
  • Sasso MS; Pritzker School for Molecular Engineering, University of Chicago, Chicago, IL, USA. melodyswartz@uchicago.edu mariastella.sasso@psioxus.com.
  • Mitrousis N; Pritzker School for Molecular Engineering, University of Chicago, Chicago, IL, USA.
  • Wang Y; Pritzker School for Molecular Engineering, University of Chicago, Chicago, IL, USA.
  • Briquez PS; Pritzker School for Molecular Engineering, University of Chicago, Chicago, IL, USA.
  • Hauert S; Pritzker School for Molecular Engineering, University of Chicago, Chicago, IL, USA.
  • Ishihara J; Pritzker School for Molecular Engineering, University of Chicago, Chicago, IL, USA.
  • Hubbell JA; Pritzker School for Molecular Engineering, University of Chicago, Chicago, IL, USA.
  • Swartz MA; Pritzker School for Molecular Engineering, University of Chicago, Chicago, IL, USA. melodyswartz@uchicago.edu mariastella.sasso@psioxus.com.
Sci Adv ; 7(13)2021 03.
Article en En | MEDLINE | ID: mdl-33762337

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Sci Adv Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Sci Adv Año: 2021 Tipo del documento: Article